The U.S. Autism Treatment Market

 Published On: Nov, 2017 |    No of Pages: 50 |  Published By: Marketdata Enterprises Inc | Format: PDF
Request Free Sample
The incidence of autism among American children has soared from 1 in 150 in 2000 to 1 in 45 today, and 2.1 million children and adults now live with autism. Yet, few therapies exist to treat this disease—just a few medications and ABA (applied behavioral analysis) programs. This is a fragmented $1.8 billion market comprised of for-profit and non-profit providers that serve autistic patients via brick & mortar centers and in-home therapy provided by therapists. Waiting lists are growing and only 36% of patients are estimated to have access to insurance coverage.

The report includes: dollar value & growth of the market from 2009 to a 2022 forecast, market structure, key metrics of treatment centers, definition of and the types of autism, typical therapies used, how ABA programs work, insurance coverage, patient demographics, analysis of the market for drugs to treat autism (Risperdal, Abilify, Ritalin), latest CDC research findings on autism, market growth factors, economic costs, and a ranking of the top treatment chains/no. of centers.

Contains 11 in-depth competitor profiles and revenues of the largest players in the field: Autism Speaks, UPMC, Centria Autism Services, The Center for Autism & Related Disorders, the May Institute, Butterfly Effects, Autism Learning Partners, Autism Spectrum Therapies, Chance Light Behavioral Health, and City Pro Group.
Study scope & methodology, sources used 4-6

Nature of The Field & Patient Demographics 7-11


Summary: Definition of Autism Spectrum Disorder, typical symptoms, incidence In the population

Types of treatments used

Non-profit vs. for-profit treatment centers

Latest CDC data on incidence of autism, increase since 2000, Rapid increase in disease population set to boost the future market

Facts about autism and the scope of the disorder, by the Autism Society Economic costs

Risk factors and characteristics

Table

-No. of children with autism by: gender, race, living in a metro area

Market Size & Growth, Market Segments 12-19

Estimates of market size and growth by other research firms

Rationale for estimating market size: by no. of treatment centers, avg. revenues per center, no. of therapists, % of children age 3-17 with autism, avg. cost of treatment programs, etc. – available information & proxy indicators

Discussion of major drivers of the market

Discussion of insurance coverage

Growth factors

List of the top 9 multi-center treatment organizations: no. of centers, actual or estimated annual revenues

Tables

-Size of the U.S. autism treatment market: 2009-2022 forecast (programs, drugs, total)
-Size of the autism medications market: 2006-2016 (Risperdal, Ritalin, others)
-Incidence of autism, no. of children with autism vs. population: 2000, 2010, 2016

ABA Treatment Programs & Competitors (Applied behavior analysis) 20-39

Discussion of types of programs: center-based, community, in-home therapy

Key metrics (no. of adults and children with autism, avg. revenues per treatment center, avg. per therapist, percent of patients using medications, percent with access to insurance coverage, estd. market value)

In-depth description of how ABA programs work, types of therapy, controversies

Description of other therapies used (TEAACH, speech therapy, occupational therapy)

Discussion of obstacles with insurance coverage, Medicare, Medicaid, other major market issues

Chart/Map
-Insurance coverage for autism treatment, by state

Competitor Profiles (Descriptions of program, number of sites and therapists, Specialties, headquarters address, estimated/actual revenues, expenses)

-Autism Treatment Network (Autism Speaks)
-Florida Autism Center
-UPMC
-Centria Autism Services
-The Center for Autism & Related Disorders (CARD)
-May Institute
-Butterfly Effects
-Autism Learning Partners
-Autism Spectrum Therapies
-ChanceLight Behavioral Health & Education
-City Pro Group

The Market For Autism Medications 40-48

Summary & Discussion of the drugs currently used to treat behavioral and emotional problems of autistic children, including mood stabilizers, antipsychotics, stimulants

List of drug companies doing research and clinical trials

Risperdal: description and uses, side effects and problems, sales

Abilify: description and uses, side effects and problems, sales

Ritalin: description and uses, side effects and problems, sales

Market Size: estimates by Marketdata, actual sales by drug companies, emergence Of less costly generics as patents expire

Future Outlook and 2022 forecasts

Table
-Estimated sales of autism drugs in the U.S. 2006-2016, 2022 forecast

Reference Directory 49-50

Directory of autism research, treatment and education organizations, societies, Institutes, magazines, reports, special surveys, experts, other information sources
If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.